Navigation Links
ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
Date:12/1/2009

SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that a new, recently completed preclinical study has affirmed the bioequivalence and comparable toxicity of ANX-514 and Taxotere® (docetaxel). Shin Poong Pharmaceuticals, ADVENTRX's partner for ANX-514 in South Korea, independently conducted the study and data analysis.

"Our independent confirmation of the bioequivalence and comparable overall safety of ANX-514 and Taxotere affirm our belief in both the emulsion platform technology underlying several ADVENTRX product candidates and its application to docetaxel," stated Mr. Byung Yong Kim, Executive Managing Director of Shin Poong Pharmaceuticals. "We intend next to conduct a separate clinical bioequivalence study of ANX-514 in South Korea and look forward to continuing to work with ADVENTRX toward the possible commercialization of ANX-514 in both the U.S. and South Korea."

About ANX-514 (docetaxel emulsion)

ANX-514 is a novel emulsion formulation of the chemotherapy drug docetaxel, a formulation of which is marketed under the brand name Taxotere. ANX-514 is formulated without polysorbate 80 or other detergents and is intended to reduce the severity and/or incidence of the hypersensitivity reactions often associated with Taxotere.

In May 2009, ADVENTRX announced the results of a clinical bioequivalence study of ANX-514. ANX-514 was determined to have comparable overall safety as Taxotere, with no differences between treatment groups in severe toxicities. However, pharmacokinetic equivalence, the primary endpoint of the study, was not demonstrated based on benchmark regulatory standards. The study data revealed higher blood-levels of docetaxel during and immediately following infusion of the study drug (i.e., during the first h
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
2. ADVENTRX Pharmaceuticals Announces Closing of Financing
3. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
4. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
5. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
6. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
7. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
8. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
9. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
10. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
11. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... MISSISSAUGA, ON , May 29, 2015 /CNW/ ... COV), an advanced medical technologies company, is delighted ... quarter ended March 31, 2015, which includes revenue ... for the quarter of $264,340. Revenue from advanced wound ... ended March 31, 2015 increased 24% to $1,742,672 ...
(Date:5/29/2015)... OAKS, Calif. , May 29, 2015 /PRNewswire/ ... pooled data from two pivotal Phase 3, global, ... calcimimetic, for the treatment of secondary hyperparathyroidism (SHPT) ... hemodialysis. Both studies met the primary endpoint, demonstrating ... AMG 416 groups achieved a greater than 30 ...
(Date:5/28/2015)... HOUSTON , May 28, 2015 /PRNewswire/ - ESSA Pharma ... results for the second quarter and three and six months ... in Canadian dollars and in accordance with International Financial Reporting ... ESSA recorded a net loss of $5.9 million ($0.35 per ... (Q2-2015), compared to a net loss of $0.4 million ($0.03 ...
Breaking Medicine Technology:Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... MOUNTAIN VIEW, Calif., April 4, 2011 VIVUS, Inc. (Nasdaq: ... patients treated with the investigational drug QNEXA® for two years ... medications as well as improvements in lipid levels following significant ... placebo group over two years. The data ...
... community pharmacy chain, has revealed that one in four* (24%) of ... has taken or applied medicines which they later discovered were out ... (53%) of people do not always check the expiry date of ... This is worrying considering that nearly one in ...
Cached Medicine Technology:Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 3Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 2Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 3
(Date:5/29/2015)... Astoria, NY (PRWEB) May 29, 2015 Thursday, ... United States. People from all walks of life came ... , Because Red Nose Day is a campaign dedicated to ... by simply having fun and making people laugh, the people ... their clinic in Astoria. Here they provided food, fun ...
(Date:5/29/2015)... Acoustiblok recently resolved a noisy well motor issue ... Municipal Water District (Three Valleys MWD) in California. Ben ... project said, “The new Acoustiblok All Weather Sound Panels ... better looking than the temporary barriers. We are pleased ... the process, and the customer service was great.” , ...
(Date:5/29/2015)... May 29, 2015 New England ... the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and ... a new product line of peptide stable isotope ... Tryptides™, or isotope labeled tryptic peptides, offers thousands ... and is now readily accessible to the biomedical ...
(Date:5/29/2015)... On May 28th, TheCelebrityDresses.com released their new range ... dresses. Most of the styles in their new collection ... than 80 styles of sexy cocktail dresses and 100 ... elements coming with the new release are color blocks, ... Many of the new styles are made of carefully ...
(Date:5/28/2015)... Kentucky (PRWEB) May 29, 2015 On Monday, ... its newest location at 160 Frankfort Road in Shelbyville, Kentucky ... oversee all operations as well as treat patients , ... provide a more convenient , local clinic to better serve ... patients first making their experience as trouble-free as possible by ...
Breaking Medicine News(10 mins):Health News:Groups, such as Hands-On Physical Therapy, Across the Country, Host Their Own Events and Make the Inaugural Red Nose Day a Huge Success 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 3Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 4Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 5Health News:New England Peptide Announces New Tryptides™ Catalog 2Health News:New England Peptide Announces New Tryptides™ Catalog 3Health News:TheCelebrityDresses.com Released New Collection of Cheap Bridesmaid and Party Dresses 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3
... of health care reform in the U.S. Senate is one historic ... will make to every person living in this country: If you ... to afford coverage and insurance companies will not run roughshod over ... include final passage after conference committee, effective implementation in the years ...
... embryonic-like cells, study finds , THURSDAY, Dec. 24 (HealthDay News) ... common cold and heal wounds, but the antioxidant might have ... stem cells, new research suggests. , The findings, published ... , add to previous research that showed how adult cells ...
... Dec. 24 The U.S. Senate bill,s historic expansion of ... of the health care system to the medical and insurance ... and state governments to monitor and police these industries and ... While the legislation requires every American to buy coverage under ...
... Speaker Nancy Pelosi issued the following statement this morning ... health insurance reform legislation: , "Today,s vote in ... affordable health insurance to every American. I commend Senator Reid ... a critical step on behalf of the health and security ...
... , WASHINGTON, Dec. 24 The following statement ... Association: , "Today, the Senate took an historic vote ... to millions of Americans and strengthening the private insurance market ... The AMA supported passage of the bill because it contains ...
... FOUNTAIN VALLEY, Calif., Dec. 24 Today Zealous, Inc. (OTC ... stake in Zealous Interactive in order to monetize the valued ... Gottlieb said, "We are in detailed talks with a major ... marketing assets owned by Zealous Interactive, a wholly owned subsidiary ...
Cached Medicine News:Health News:A Promise to Keep. Senate Vote is the First Step Toward the Promise of Quality, Affordable Health Care for All 2Health News:Historic Expansion of Health Insurance Coverage Cedes Control to Medical/Insurance Industries 2Health News:Historic Expansion of Health Insurance Coverage Cedes Control to Medical/Insurance Industries 3Health News:AMA: Senate Bill Passage Historic, More Work to Do in Conference 2Health News:Zealous in Talks to Sell Its Interactive Subsidiary; Company Said to be Considering All Options. 2
This table has an adjustable height, two legs, and square post. Clamps and standard 1" (2.5 cm) pad included....
... This table is designed ... in many procedures, allowing for ... auxiliary leg is stored onboard ... Post brackets quickly slide ...
Built-in accessory rail clamps quickly mount to any standard O.R. table or stretcher. The leg, available in single post or double tee adjusts with a simple twist. Optional armrests are available. Wal...
Light weight, clear imaging, attaches easily, perfect size, optional leg, table cart....
Medicine Products: